5-DEUTERO-2,4-THIAZOLIDINEDIONE AND 5-DEUTERO-2,4-OXAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
申请人:DeuteRx, LLC
公开号:US20140221369A1
公开(公告)日:2014-08-07
The invention provides 5-deuterium enriched 2,4-thiazolidinediones and 2,4-oxazolidinediones, such as 5-(4-((6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1H-benzo[d]imidazol-2-yl)methoxy)benzyl)-5-deutero-thiazolidine-2,4-dione, deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treating medical disorders, such as cancer, using the same.
该发明提供了5-氘富集的2,4-噻唑烷二酮和2,4-噁唑烷二酮,例如5-(4-((6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并[d]咪唑-2-基)甲氧基)苄基)-5-氘噻唑烷-2,4-二酮,其氘代衍生物,其立体异构体,其药学上可接受的盐形式,以及使用它们治疗医学疾病(例如癌症)的方法。